769126-84-3

Upstream product

• 3150-15-0 methyl 2,3-anhydro-4,6-O-benzilidene-α-D-mannopyranoside 
• 131529-45-8 methyl 4,6-O-benzylidene-3-deoxy-3-(prop-2-enyl)-α-D-altropyranoside 
• 769126-82-1 methyl 4,6-O-benzylidene-2-(tert-butyldimethylsilyloxy)-3-deoxy-3-[(3-pivaloyloxy)propyl]-α-D-altropyranoside 
• 769126-81-0 methyl 4,6-O-benzylidene-3-deoxy-3-[(3-pivaloyloxy)propyl]-α-D-altropyranoside 
• 769126-80-9 methyl 4,6-O-benzylidene-3-deoxy-3-C-(3-hydroxypropyl)-α-D-altopyranoside 

Downstream Products

• 769126-85-4 (3R,4R)-3-[(benzoyl)oxy]-4-(S)-oxyranyl-7-(pivaloyloxy)hept-1-ene 
• 769126-86-5 Benzoic acid (1R,2R)-2-[(S)-1-(tert-butyl-dimethyl-silanyloxy)-2-(toluene-4-sulfonyloxy)-ethyl]-5-(2,2-dimethyl-propionyloxy)-1-vinyl-pentyl ester 

Relevant academic research and scientific papers

24,24-Dimethylvitamin D3-26,23-lactones and their 2α-functionalized analogues as highly potent VDR antagonists

Novel vitamin D receptor (VDR) antagonists, 24,24-dimethyl-1α- hydroxyvitamin D3-26,23-lactones (8 and 9) and their C2α functionalized analogues (8a-c and 9a-c) were efficiently synthesized and their biological activities were evaluated. The co